Issue 7, 2007

Inhibition of lysine biosynthesis: an evolving antibiotic strategy

Abstract

Bacterial biosynthesis of lysine has come under increased scrutiny as a target for novel antibacterial agents as it provides lysine for protein synthesis and both lysine and meso-diaminopimelate for construction of the bacterial peptidoglycancell wall. In this Highlight article we review recent advances in the validation of antibiotic targets, studies of the enzymes of the lysine biosynthetic pathway and development of inhibitors of these enzymes.

Graphical abstract: Inhibition of lysine biosynthesis: an evolving antibiotic strategy

Article information

Article type
Highlight
First published
23 May 2007

Mol. BioSyst., 2007,3, 458-465

Inhibition of lysine biosynthesis: an evolving antibiotic strategy

C. A. Hutton, M. A. Perugini and J. A. Gerrard, Mol. BioSyst., 2007, 3, 458 DOI: 10.1039/B705624A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements